Allergic contact dermatitis due to timolol and levobunolol in eyedrops, with no cross-sensitivity to other ophthalmic beta-blockers.
Hautklinik der Universität des Saarlandes, Homburg/Saar, Germany.
P
P
Koch
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D003429:Cross Reactions; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D002040:Levobunolol / Q000009:adverse effects* / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D010328:Patch Tests; D013999:Timolol / Q000009:adverse effects* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D013999:Timolol; D002040:Levobunolol